Download Citation
Article Source:
DW-MRI as a Biomarker to Compare Therapeutic Outcomes in Radiotherapy Regimens Incorporating Temozolomide or Gemcitabine in Glioblastoma
Galbán S,
Lemasson B,
Williams TM,
Li F,
Heist KA,
et al.
(2012)
DW-MRI as a Biomarker to Compare Therapeutic Outcomes in Radiotherapy Regimens Incorporating Temozolomide or Gemcitabine in Glioblastoma.
PLOS ONE 7(4): e35857.
https://doi.org/10.1371/journal.pone.0035857